NCT04663399View on ClinicalTrials.gov

IMMunological ResPonse Assessment AfteR Acute ISchemic Stroke Treated with Endovascular Therapy (IMPRESS)

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

May 23, 2028

Study Completion Date

May 23, 2028

Conditions
Ischemic StrokeThrombectomy
Interventions
OTHER

Prospective patient

The immuno-inflammatory and thrombo-inflammatory profiles will be evaluated at inclusion, and at 24 hours +/- 12 hours of the reperfusion treatment.

Trial Locations (1)

75019

RECRUITING

Hôpital Fondation Adolphe de Rothschild, Paris

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK